SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Financial Advocates Investment Management

Financial Advocates Investment Management cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 69.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 3,699 shares of the exchange traded fund’s stock after selling 8,269 shares during the quarter. Financial Advocates Investment Management’s holdings in SPDR S&P Biotech ETF were worth $333,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund grew its position in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $141,284,000. Mirae Asset Securities USA Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares in the last quarter. Assetmark Inc. raised its position in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the period. Finally, Whittier Trust Co. lifted its stake in SPDR S&P Biotech ETF by 3.3% in the 3rd quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock worth $30,729,000 after acquiring an additional 9,976 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $91.24 on Monday. The stock has a market cap of $6.95 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The stock’s 50-day moving average is $92.58 and its two-hundred day moving average is $96.46.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.